Business Continuity Update

At Magellan Rx Management, we are taking the health implications of coronavirus (COVID-19) very seriously. Our Business Continuity Management team is monitoring information from the Centers for Disease Control and Prevention (CDC), the World Health Organization (WHO), the U.S. Food & Drug Administration (FDA), the individual state departments of health and other experts. Read our business continuity update here.

It is important to recognize that this situation is evolving daily, and we are prepared to follow federal and state guidance regarding the well-being and support of our customers, members, and Magellan team members. Read our press release: Magellan Health Offers Support to Individuals and Customers in Response to the Coronavirus Pandemic.

Magellan Rx is dedicated to keeping you informed

There is a lot of information about COVID-19 and it can be hard to sort through what is important. As always, it is imperative to check trusted and reliable sources, like the the CDC, WHO, and the FDA, and to also follow state and local guidelines that impact you directly. Check out the latest from our team:


The FDA, PBMs and the COVID-19 pandemic

There has been a lot of information on COVID-19 treatments and therapies and how quickly they will come to market. Our Chief Medical Officer, Dr. Caroline Carney, sat down to answer some key questions about COVID-19, the FDA and PBMs.

Educational Resources

help staff members during distress | Magellan Rx Management

tips to manage anxiety | Magellan Rx Management

information about covid-19 | Magellan Rx Management

Resources from our partners at Magellan Healthcare

crisis communication | Magellan Rx Management

mental health resources | magellan rx management

Other helpful resources